Projects per year
Fingerprint Dive into the research topics where Kenneth Krohn is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 5 Similar Profiles
Positron-Emission Tomography
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Fluorodeoxyglucose F18
Medicine & Life Sciences
Radiopharmaceuticals
Medicine & Life Sciences
Thymidine
Medicine & Life Sciences
Glioma
Medicine & Life Sciences
Misonidazole
Medicine & Life Sciences
Radiation
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1983 2016
- 6 Finished
cyclotrons
positrons
isotopes
tomography
radioactive isotopes
Insulin-Secreting Cells
B-Lymphocytes
Insulin
Artificial Organs
Islets of Langerhans
blood flow
tracers
generators
isotopes
cyclotrons
METABOLIC IMAGING OF CANCER AND ITS RESPONSE TO THERAPY
Krohn, K., Link, J., Shields, A. F., Graham, M. M., Lewellen, T. K., Rasey, J., Rajendran, J., Conrad, E., Pickett, C., Tait, J., Mankoff, D., Spence, A., Eary, J. F. & Lewellen, T. K.
5/1/86 → 8/31/16
Project: Research project
Radiopharmaceuticals
Molecular Imaging
Neoplasms
Therapeutics
Radiation
RADIOPROTECTIVE DRUGS--MECHANISM AND BIOLOGICAL STUDIES
Krohn, K. & Rasey, J.
12/1/83 → 4/30/94
Project: Research project
Radiation-Protective Agents
Photons
Neoplasms
Pharmaceutical Preparations
Cyclotrons
Research Output 1971 2017
A complementary radiopharmaceutical and mathematical model for quantitating hepatic-binding protein receptors
Krohn, K., Vera, D. R. & Stadalnik, R. C., Jan 1 2017, Receptor Binding Radiotracers. CRC Press, Vol. 2. p. 41-59 19 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
Radiopharmaceuticals
Theoretical Models
Peptides
Carbohydrate Sequence
Membrane Glycoproteins
10
Citations
(Scopus)
A simple thick target for production of 89Zr using an 11 MeV cyclotron
Link, J., Krohn, K. & O'Hara, M. J., Apr 1 2017, In : Applied Radiation and Isotopes. 122, p. 211-214 4 p.Research output: Contribution to journal › Article
cyclotrons
foils
radiochemistry
yttrium
availability
29
Citations
(Scopus)
Estrogen receptor binding (18F-FES PET) and glycolytic activity (18F-FDG PET) predict progression-free survival on endocrine therapy in patients with ER+ breast cancer
Kurland, B. F., Peterson, L. M., Lee, J. H., Schubert, E. K., Currin, E. R., Link, J., Krohn, K., Mankoff, D. A. & Linden, H. M., Jan 15 2017, In : Clinical Cancer Research. 23, 2, p. 407-415 9 p.Research output: Contribution to journal › Article
Fluorodeoxyglucose F18
Estrogen Receptors
Disease-Free Survival
Breast Neoplasms
Aromatase Inhibitors
4
Citations
(Scopus)
Glioma FMISO PET/MR imaging concurrent with antiangiogenic therapy: Molecular imaging as a clinical tool in the burgeoning era of personalized medicine
Barajas, R., Krohn, K., Link, J., Hawkins, R. A., Clarke, J. L., Pampaloni, M. H. & Cha, S., Dec 1 2016, In : Biomedicines. 4, 4, 24.Research output: Contribution to journal › Article
Molecular imaging
Precision Medicine
Positron emission tomography
Molecular Imaging
Glioma
4
Citations
(Scopus)
Imaging hypoxia with 18F-fluoromisonidazole: Challenges in moving to a more complicated analysis
Muzi, M. & Krohn, K., Apr 1 2016, In : Journal of Nuclear Medicine. 57, 4, p. 497-498 2 p.Research output: Contribution to journal › Article
Misonidazole
Radiopharmaceuticals
Head and Neck Neoplasms
Squamous Cell Carcinoma
Hypoxia